BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 29552508)

  • 1. Polygenic signal for symptom dimensions and cognitive performance in patients with chronic schizophrenia.
    Xavier RM; Dungan JR; Keefe RSE; Vorderstrasse A
    Schizophr Res Cogn; 2018 Jun; 12():11-19. PubMed ID: 29552508
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Genetic correlates of insight in schizophrenia.
    Xavier RM; Vorderstrasse A; Keefe RSE; Dungan JR
    Schizophr Res; 2018 May; 195():290-297. PubMed ID: 29054485
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Schizophrenia Polygenic Risk Score as a Predictor of Antipsychotic Efficacy in First-Episode Psychosis.
    Zhang JP; Robinson D; Yu J; Gallego J; Fleischhacker WW; Kahn RS; Crespo-Facorro B; Vazquez-Bourgon J; Kane JM; Malhotra AK; Lencz T
    Am J Psychiatry; 2019 Jan; 176(1):21-28. PubMed ID: 30392411
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Polygenic risk for schizophrenia and neurocognitive performance in patients with schizophrenia.
    Wang SH; Hsiao PC; Yeh LL; Liu CM; Liu CC; Hwang TJ; Hsieh MH; Chien YL; Lin YT; Chandler SD; Faraone SV; Laird N; Neale B; McCarroll SA; Glatt SJ; Tsuang MT; Hwu HG; Chen WJ
    Genes Brain Behav; 2018 Jan; 17(1):49-55. PubMed ID: 28719030
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A Polygenic Risk Score of glutamatergic SNPs associated with schizophrenia predicts attentional behavior and related brain activity in healthy humans.
    Rampino A; Taurisano P; Fanelli G; Attrotto M; Torretta S; Antonucci LA; Miccolis G; Pergola G; Ursini G; Maddalena G; Romano R; Masellis R; Di Carlo P; Pignataro P; Blasi G; Bertolino A
    Eur Neuropsychopharmacol; 2017 Sep; 27(9):928-939. PubMed ID: 28651857
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Polygenic risk score, genome-wide association, and gene set analyses of cognitive domain deficits in schizophrenia.
    Nakahara S; Medland S; Turner JA; Calhoun VD; Lim KO; Mueller BA; Bustillo JR; O'Leary DS; Vaidya JG; McEwen S; Voyvodic J; Belger A; Mathalon DH; Ford JM; Guffanti G; Macciardi F; Potkin SG; van Erp TGM
    Schizophr Res; 2018 Nov; 201():393-399. PubMed ID: 29907492
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Associations Between Schizophrenia Polygenic Liability, Symptom Dimensions, and Cognitive Ability in Schizophrenia.
    Legge SE; Cardno AG; Allardyce J; Dennison C; Hubbard L; Pardiñas AF; Richards A; Rees E; Di Florio A; Escott-Price V; Zammit S; Holmans P; Owen MJ; O'Donovan MC; Walters JTR
    JAMA Psychiatry; 2021 Oct; 78(10):1143-1151. PubMed ID: 34347035
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Common genetic variation and schizophrenia polygenic risk influence neurocognitive performance in young adulthood.
    Hatzimanolis A; Bhatnagar P; Moes A; Wang R; Roussos P; Bitsios P; Stefanis CN; Pulver AE; Arking DE; Smyrnis N; Stefanis NC; Avramopoulos D
    Am J Med Genet B Neuropsychiatr Genet; 2015 Jul; 168B(5):392-401. PubMed ID: 25963331
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Role of 108 schizophrenia-associated loci in modulating psychopathological dimensions in schizophrenia and bipolar disorder.
    Fabbri C; Serretti A
    Am J Med Genet B Neuropsychiatr Genet; 2017 Oct; 174(7):757-764. PubMed ID: 28786528
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Genome-wide association analyses of symptom severity among clozapine-treated patients with schizophrenia spectrum disorders.
    Okhuijsen-Pfeifer C; van der Horst MZ; Bousman CA; Lin B; van Eijk KR; Ripke S; Ayhan Y; Babaoglu MO; Bak M; Alink W; van Beek H; Beld E; Bouhuis A; Edlinger M; Erdogan IM; Ertuğrul A; Yoca G; Everall IP; Görlitz T; ; Grootens KP; Gutwinski S; Hallikainen T; Jeger-Land E; de Koning M; Lähteenvuo M; Legge SE; Leucht S; Morgenroth C; Müderrisoğlu A; Narang A; Pantelis C; Pardiñas AF; Oviedo-Salcedo T; Schneider-Thoma J; Schreiter S; Repo-Tiihonen E; Tuppurainen H; Veereschild M; Veerman S; de Vos M; Wagner E; Cohen D; Bogers JPAM; Walters JTR; Yağcıoğlu AEA; Tiihonen J; Hasan A; Luykx JJ
    Transl Psychiatry; 2022 Apr; 12(1):145. PubMed ID: 35393395
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Genetic contributions to transdiagnostic symptom dimensions in patients with major depressive disorder, bipolar disorder, and schizophrenia spectrum disorders.
    David FS; Stein F; Andlauer TFM; Streit F; Witt SH; Herms S; Hoffmann P; Heilmann-Heimbach S; Opel N; Repple J; Jansen A; Nenadić I; Papiol S; Heilbronner U; Kalman JL; Schaupp SK; Senner F; Schulte EC; Falkai PG; Schulze TG; Dannlowski U; Kircher T; Rietschel M; Nöthen MM; Krug A; Forstner AJ
    Schizophr Res; 2023 Feb; 252():161-171. PubMed ID: 36652833
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Schizophrenia Polygenic Risk and Brain Structural Changes in Methamphetamine-Associated Psychosis in a South African Population.
    Passchier RV; Stein DJ; Uhlmann A; van der Merwe C; Dalvie S
    Front Genet; 2020; 11():1018. PubMed ID: 33133134
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Polygenic Risk Score associated with specific symptom dimensions in first-episode psychosis.
    Sengupta SM; MacDonald K; Fathalli F; Yim A; Lepage M; Iyer S; Malla A; Joober R
    Schizophr Res; 2017 Jun; 184():116-121. PubMed ID: 27916287
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Interaction Testing and Polygenic Risk Scoring to Estimate the Association of Common Genetic Variants With Treatment Resistance in Schizophrenia.
    Pardiñas AF; Smart SE; Willcocks IR; Holmans PA; Dennison CA; Lynham AJ; Legge SE; Baune BT; Bigdeli TB; Cairns MJ; Corvin A; Fanous AH; Frank J; Kelly B; McQuillin A; Melle I; Mortensen PB; Mowry BJ; Pato CN; Periyasamy S; Rietschel M; Rujescu D; Simonsen C; St Clair D; Tooney P; Wu JQ; Andreassen OA; Kowalec K; Sullivan PF; Murray RM; Owen MJ; MacCabe JH; O'Donovan MC; Walters JTR; ; Ajnakina O; Alameda L; Barnes TRE; Berardi D; Bonora E; Camporesi S; Cleusix M; Conus P; Crespo-Facorro B; D'Andrea G; Demjaha A; Do KQ; Doody GA; Eap CB; Ferchiou A; Di Forti M; Guidi L; Homman L; Jenni R; Joyce EM; Kassoumeri L; Khadimallah I; Lastrina O; Muratori R; Noyan H; O'Neill FA; Pignon B; Restellini R; Richard JR; Schürhoff F; Španiel F; Szöke A; Tarricone I; Tortelli A; Üçok A; Vázquez-Bourgon J
    JAMA Psychiatry; 2022 Mar; 79(3):260-269. PubMed ID: 35019943
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Testing for polygenic effects in genome-wide association studies.
    Pan W; Chen YM; Wei P
    Genet Epidemiol; 2015 May; 39(4):306-16. PubMed ID: 25847094
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Associations between psychiatric polygenic risk scores and general and specific psychopathology symptoms in childhood and adolescence between and within dizygotic twin pairs.
    Chen C; Lu Y; Lundström S; Larsson H; Lichtenstein P; Pettersson E
    J Child Psychol Psychiatry; 2022 Dec; 63(12):1513-1522. PubMed ID: 35292971
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The Relationship Between Polygenic Risk Scores and Cognition in Schizophrenia.
    Richards AL; Pardiñas AF; Frizzati A; Tansey KE; Lynham AJ; Holmans P; Legge SE; Savage JE; Agartz I; Andreassen OA; Blokland GAM; Corvin A; Cosgrove D; Degenhardt F; Djurovic S; Espeseth T; Ferraro L; Gayer-Anderson C; Giegling I; van Haren NE; Hartmann AM; Hubert JJ; Jönsson EG; Konte B; Lennertz L; Olde Loohuis LM; Melle I; Morgan C; Morris DW; Murray RM; Nyman H; Ophoff RA; ; van Os J; ; ; Petryshen TL; Quattrone D; Rietschel M; Rujescu D; Rutten BPF; Streit F; Strohmaier J; Sullivan PF; Sundet K; Wagner M; Escott-Price V; Owen MJ; Donohoe G; O'Donovan MC; Walters JTR
    Schizophr Bull; 2020 Feb; 46(2):336-344. PubMed ID: 31206164
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Polygenic associations of neurodevelopmental genes in suicide attempt.
    Sokolowski M; Wasserman J; Wasserman D
    Mol Psychiatry; 2016 Oct; 21(10):1381-90. PubMed ID: 26666204
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Interplay between Schizophrenia Polygenic Risk Score and Childhood Adversity in First-Presentation Psychotic Disorder: A Pilot Study.
    Trotta A; Iyegbe C; Di Forti M; Sham PC; Campbell DD; Cherny SS; Mondelli V; Aitchison KJ; Murray RM; Vassos E; Fisher HL
    PLoS One; 2016; 11(9):e0163319. PubMed ID: 27648571
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Associations between polygenic risk, negative symptoms, and functional connectome topology during a working memory task in early-onset schizophrenia.
    Deng M; Liu Z; Zhang W; Wu Z; Cao H; Yang J; Palaniyappan L
    Schizophrenia (Heidelb); 2022 Jun; 8(1):54. PubMed ID: 35853905
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.